Tuesday, October 11, 2022 1:24:01 PM
We are waiting for the NIH to release the data on that puzzling trial.
We are also getting close for the results from the Dr. Jörg Leuppi inhaler phase 2 trial (Dec 2022). It says 82 patients, but I'm pretty sure they have increased that size to 132 patients.
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS
https://clinicaltrials.gov/ct2/show/NCT04536350
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM